• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Lorillard Bonds Attractive Ahead of FDA Ruling

    Worries about the FDA's ruling on the relative safety of menthol cigarettes have left Lorillard's bonds looking attractively priced according to Morningstar's Dave Sekera.

  2. The Moat in Your Medicine Cabinet

    Aptar COO Steve Hagge on how the firm's close client relationships and FDA-approved dispensers give the firm an advantage in consumer packaging.

  3. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

  4. No Shortage of Suitors for Genzyme

    Facing dwindling drug pipelines, plenty of big pharma firms may end up jumping into the bidding for Genzyme, according to Morningstar's Karen Andersen.

  1. Isis Pharmaceuticals ISIS Q2 2012 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to Isis Pharmaceuticals' Second Quarter Financial Results Conference Call. Leading the call today from Isis is Dr. Stanley Crook, Isis's Chairman and Chief Executive Officer. Dr. Crook, please begin.

  2. Will Regulatory Issues Hold Monster Back in 2013?

     

  3. Vertex VRTX Q4 2012 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to the Vertex Pharmaceuticals Incorporated Fourth Quarter 2012 Earnings and Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at ...

  4. 6 Top Consumer Goods Stocks for 2011

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.